Abstract
Histiocytosis X is a systemic disease characterized by the proliferation and infiltration of Langerhans’ cells in various organs [1–4]. The disease can manifest as an isolated disorder (i.e., eosinophilic granuloma of lung or bone) or as a systemic disease with multiple involvement including the skeletal, lung, reticuloendothelial system, skin and genitourinary system. The disseminated forms are more likely to appear in children and adolescents. In adults, disease isolated to lung is most common. There are some adult cases of eosinophilic granuloma of the lung in which skeletal and posterior pituitary gland involvement are present. However, systemic dissemination of histiocytosis X is less common in the adult populations. Furthermore, although the disseminated forms are more apt to occur in younger individuals, isolated organ involvement can also occur. There is sufficient evidence to suggest that the systemic forms of histiocytosis X are clonal neoplastic disorders of the Langerhans’ cell, thereby differentiating the systemic from the localized forms [2]. Most adult forms of histiocytosis X fall into the category of eosinophilic granuloma of the lung also referred to as Langerhans’ cell granulomatosis of the lung or pulmonary histiocytosis X.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
1.Hance AJ, Cadranel J, Soler P et al. (1988) Pulmonary and extra pulmonary Langerhan cell granulomatosis (Histiocytosis X). Semin Respir Med 9: 349–68.
Willman CL, Busqué L, Griffith BB et al. (1994) Langerhans’ cell histiocytosis (histiocytosis X) - a clonal proliferative disease. N Engl J Med 331: 154–60.
Basset F, Corrin B, Spencer H et al. (1978) Pulmonary histiocytosis X. Am Rev Respir Dis 118: 811–19.
Friedman PJ, Liebow AA, Sokoloff J (1981) Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult. Medicine 60: 385–96.
Basset F, Soler P, Wyllie L et al. (1976) Langerhans cells and lung interstitium. Ann NY Acad Sci 278: 599–611.
Basset F, Soler P, Jaurand MC et al. (1977) Ultrastructural examination of bronchoalveolar lavage for diagnosis of pulmonary histiocytosis X. Thorax 32: 303–6.
Travis WD, Borok Z, Roum JH et al. (1993) Pulmonary Langerhans’ cell granulomatosis (histiocytosis X): a clinicopathologic study of 48 cases. Am J Surg Pathol 17: 971–86.
Kawanami O, Basset F, Ferrans VJ et al. (1980) Pulmonary Langerhans’ cells in patients with fibrotic lung disorders. Lab Invest 44: 227–33.
Auerswald V, Barth J, Magnussen H (1991) Value of CD-I positive cells in bronchoalveolar lavage fluid for the diagnosis of pulmonary histiocytosis X. Lung 169: 305–9.
Murphy GF, Bhan AK, Sato S et al. (1981) A new immunologic marker for human Langerhans’ cells. N Engl J Med 304: 791–2.
Soller P, Chollet S, Jacque C et al. (1985) Immunocytochemical characterization of pulmonary histiocytosis X cells in lung biopsies. Am Pathol 118: 439–51.
Cocchia D, Michetti F, Donato R (1981) Immuno-chemical and immunocytochemical localization of S-100 antigen in normal human skin. Nature 294: 85–7.
Casolaro MA, Bernaudin JF, Saltini C et al. (1988) Accumulation of Langerhans’ cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking. Am Rev Respir Dis 137: 406–11.
Soler P, Moreau A, Bassett F et al. (1989) Cigarette smoking induced charges in the number and differ-entiated state of pulmonary dendritic cells/ Langerhans’ cells. Am Rev Respir Dis 139: 1112–17.
Aguayo SM, Kane MA, King TE et al. (1989) Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic smokers. J Clin Invest 84: 1105–13.
Aguayo SM, King TE, Waldron JA et al. (1990) Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma. J Clin Invest 86: 838–44.
Auld D (1957) Pathology of eosinophilic ganuloma of lung. Arch Pathol 63: 113–31.
Lewis JG (1964) Eosinophilic granuloma and its variants with special reference to lung involvement: a report of 12 patients. Q J Med 131: 337–59.
Kulwiec E, Lynch D, Aguayo S et al. (1992) Imaging of Pulmonary Histiocytosis S. Radiographics 12: 515–26.
Grenier P, Valeyre D, Cluzel P et al. (1991) Chronic diffuse interstitial lung disease: diagnostic value of chest radiography and high resolution CT. Radiology 179: 123–32.
Brauner MW, Grenier P, Mouelhi MM et al. (1989) Pulmonary histiocytosis X: evaluation with high- resolution CT. Radiology 172: 255–8.
Moore A, Godwin J, Muller N et al. (1989) Pulmonary histiocytosis S: Comparison of radiographic and CT findings. Radiology 172: 249–54.
Taylor DB, Joske D, Anderson J et al. (1990) Cavitating pulmonary nodules in histiocytosis-X high resolution CT demonstration. Australas Radiol 34: 253–5.
Chusid EL (1966) Pulmonary eosinophilic granuloma. Aspects of pulmonary function. Mt. Sinai Hosp J 33: 116.
Hoffman L, Cohn JE, Guenster EA (1961) Respiratory abnormalities in eosinophilic granuloma of the lung. Long term study of five cases. N Engl J Med 267: 377–589.
Crausman RS, Jennings CA, Tuder RM et al. (1996) Pulmonary histiocytosis X: Pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med 153: 426–35.
Weinberger SE, Kelman JA, Elson NA et al. (1978) Bronchoalveolar lavage fluid in interstitial lung disease. Ann Intern Med 89: 459–66.
Housini I, Tomashefski JF, Cohen A et al. (1994) Transbronchial biopsy in patients with pulmonary eosinophilic granuloma: comparison with findings in open lung biopsy. Arch Pathol Lab Med 118: 523–30.
Delobbe A, Durieu J, Duhamel A et al. (1996) Determination of survival in pulmonary Langerhan’s cell granulomatosis. Eur Respir J 9: 2002–6.
von Essen S, West W, Sitorius M et al. (1990) Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X. Chest 98: 765–7.
Shonfeld N, Frank W, Wenig S et al. (1993) Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration 60: 38–44.
Benyounes B, Crestani B, Couveland A et al. (1996) Steroid-responsive pulmonary hypertension in a patient with Langerhan’s cell granulomatosis (histi-ocytosis X). Chest 110: 284–6.
Taylor JR, Ryu J, Colby TV et al. (1990) Lymph- angioleiomyomatosis: clinical course in 32 patients. N Engl J Med 323: 1254–60.
Corrin B, Liebow AA, Friedman PJ (1975) Pulmonary lymphangiomyomatosis: A review. Am J Pathol 79: 348–82.
Allaf DE, Borlee G, Hadjouj H et al. (1984) Pulmonary lymphangiomyomatosis. Eur J Respir Dis 65: 147–52.
Tazelaar HD, Kerr D, Yousem SA et al. (1993) Diffuse pulmonary lymphangiomatosis. Hum Pathol 24: 1313–22.
Kitaichi M, Nishimura K, Itott H et al. (1995) Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am Respir Crit Care Med 151: 527–33.
Bernstein SM, Newell JD, Adamczy KD et al. (1995) How common are renal angiomyolipomas in patients with pulmonary lymphangioleiomyomatosis? Am J Respir Crit Care Med 152: 2138–43.
Aberle Dr, Hansell DM, Brown K et al. (1990) Lymphangiomyomatosis: CT, chest radiographic, and functional correlations. Radiology 176: 381–7.
Horwitz T, Friedman L (1991) Findings on computed tomography of the chest in lymphangiomyomatosis. S Afr Med J 79: 53–4.
Lenoir S, Grenier P, Brauner MW et al. (1990) Pulmonary lymphangiomyomatosis and tuerous sclerosis: comparison of radiographc and thin- section CT findings. Radiology 175: 329–34.
Muller NL, Chiles C, Kullnig P (1990) Pulmonary lymphangiomyomatosis: correlation of CT with radiographic and functional findings. Radiology 175: 335–9.
Crausman R, Lynch D, Mortenson R et al. (1996) Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomymomatosis. Chest 109: 131–7.
Bernstein S, Adamczyk D, Mortenson R, Jr TK, Lynch D (1995) How common are renal angiomy-olipomas in patients with pulmonary lymphan-giomyomatosis? Am J Respir Crit Care Med 152: 2138–43.
Crausman RS, Jennings CA, Mortenson RL et al. (1996) Lymphangioleiomyomatosis: the pathophys-iology of diminished exercise capacity. Am J Respir Crit Care Med 153: 1368–76.
Carrington CB, Cugell DW, Gaensler EA et al. (1977) Lymphangioleiomyomatosis. Physiologic pathologie-radiologie correlations. Am Rev Respir Dis 116: 977–95.
Shen A, Iseman MD, Waldron JA et al. (1987) Exacerbation of pulmonary lymphangioleiomy-omatosis by exogenous estrogens. Chest 91: 782–4.
McCarty KS, Jr, Mossier JA, McLelland R et al. (1980) Pulmonary lymphangiomyomatosis responsive to progesterone. N Engl J Med 303: 1461–5.
Yockey CC, Riepe RE, Ryan K (1986) Pulmonary lymphangioleiomyomatosis complicated by preg-nancy. Kans Med 87: 277–93.
Sawicka ETT, Morris AJR (1985) A report of two long standing cases of pulmonary lymphang- iolieomyomatosis and the response to progesterone therapy. Br J Dis Chest 79: 400–16.
Svendsen TL, Viskum K, Hansborg N et al. (1984) Pulmonary lymphangioleiomyomatosis: a case of progesterone receptor positive lymphangioleiomy-omatosis leison treated with medroxyprogesterone, oophorectomy and tamoxifen. Br J Dis Chest 78: 264–71.
Banner AS, Carrington CB, Emory WB et al. (1981) Efficacy of oophorectomy in lymphangioleiomy-omatosis and benign metastasizing leiomyoma. N Engl J Med 305: 204–9.
Adamson D, Heinrichs WL, Raybin DM et al. (1985) Successful treatment of pulmonary lymphangiomy-omatosis with oophorectomy and progesterone. Am Rev Respir Dis 132: 916–21.
Eliasson AH, Phillips YY, Tenholder MF (1989) Treatment of lymphoangioleiomyomatosis. Chest 196: 1352–5.
Boehler A, Speich R, Russi EW et al. (1996) Lung transplantation for lymphoangioleiomyomatosis. N Engl J Med 335: 1275–80.
O’Brien JD, Lium JH, Parosa JF et al. (1995) Lymphangioleiomyomatosis recurrance in the allograft after single-lung transplantation. Am J Respir Crit Care Med 151: 2033–6.
Marshall D, Saul GB, Sach E (1959) Tuberous sclero-sis. A report of 16 cases in two family trees revealing genetic dominance. N Engl J Med 261: 1102–3.
Jin F, Wienecke R, Xiao GH et al. (1996) Suppression of tumorgenicity by the wild type tuberous sclerosis 2(Tsc2) gene and its C-terminal region. Proc Natl Acad Sei USA 93: 9154–9.
Dwyer JH, Hickie JB, Garvan J (1971) Pulmonary tuberous sclerosis: report of three patients and a review of the literature. Q J Med 40: 115–25.
Rosenberg DM (1982) Inherited forms of interstitial lung disease. Clin Chest Med 3: 635–41.
Aughenbaugh GL (1984) Thoracic manifestations of neurocutaneous diseases. Radiol Clin of N America 22: 741–56.
Medley BE, McLeod RA, Houser OW (1976) Tuberous sclerosis. Semin Roentgenol 11: 35–54.
Castro M, Shepard CW, Gomez MR et al. (1995) Pulmonary tuberous sclerosis. Chest 107: 189–95.
Riccardi VM (1981) von Recklinghausens neuro-fibromatosis. N Engl J Med 305:1616–27.
Webb WR, Goodman PC (1977) Fibrosing alveolitis in patients with neurofibromatosis. Radiology 122: 289–93.
Shimizu Y, Tsuchiya A, Watanabe S etal. (1994) von-Recklinghausen’s disease with lung cancer derived from the wall of emphysematous bullae. Int Med 33: 167–71.
Volpini E, Conuertino G, Fulgoni P et al. (1996) Pulmonary changes in a man affected by von- Recklinghausen’s disease. Minaldi Arch of Chest Dis 51: 123–4.
Scheerder ID, Elinck W, Renterghem DV et al. (1984) Desquamative interstitial pneumonia and scar cancer of the lung complicating generalized neurofibromatosis. Eur J Respir Dis 65: 623–6.
Patchefsky AS, Atkinson WG, Hoch WS et al. (1973) Interstitial pulmonary fibrosis and von- Recklinghausen’s disease: an ultrastructural and immunofluorescent study. Chest 64: 459–64.
Liebow AA, Steer A, Billingsley JG (1965) Desquamative interstitial pneumonia. Am J Med 59: 369–404.
Scadding JG (1974) Diffuse pulmonary alveolar fibrosis of the thorax. 29: 271–81.
Tubbs RR, Benjamin SP, Reich NE et al. (1977) Desquamative interstitial pneumonitis: cellular phase of fibrosing alveolitis. Chest 72: 159–69.
Lougheed MD, Roos JO, Waddell WR et al. (1995) Desquamative interstitial pneumonitis and diffuse alveolar damage in textile workers: potential role of myxotoxins. Chest 108: 1196–2000.
Klocke RA, Augersum WS, Berman HH et al. (1967) Desquamative interstitial pneumonia: a disease with a wide clinical spectrum. Ann Int Med 66: 498–506.
McCann BG, Brewer DB (1974) A case of desquamative interstitial pneumonia progressing to honeycomb lung. J Pathol 112: 199–202.
Kuisk H, Sanchez JS (1969) Desquamative interstitial pneumonia and idiopathic diffuse pulmonary fibrosis. Am J Roentgen 107: 258–79.
Carrington CB, Gaensler EA, Coutu RE et al. (1978) N Engl J Med 298: 801–9.
Patchefsky AS, Fraimow MD, Hoch WS (1973) Desquamative interstitial pneumonia: pathologic findings and follow-up in 13 patients. Arch Intern Med. 132: 222–5.
Hartman TE, Primack SL, Sensen SJ et al. (1993) Desquamative interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 187: 787–90.
Hartman TE, Primack SL, Kang EY et al. (1996) Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia. Assessment with serial CT. Chest 110: 378–82.
Allen JN, Davis WB (1994) Eosinophilic lung diseases. Am J Respir Crit Care Med 150: 1423–38.
Badesch DB, King TE, Schwarz MI (1989) Acute eosinophilic pneumonia: a hypersensitivity phe-nomenon? Am Rev Respir Dis 139: 249–52.
Allen JN, Pacht ER, Gadek JE et al. (1989) Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 321: 569–74.
Buchheit J, Eid N, Rodgers G, Jr, et al. (1992) Acute eosinophilic pneumonia with respiratory failure: a new syndrome? Am Rev Respir Dis 145: 716–8.
St. John R, Allen JN, Pacht ER (1990) Acute eosinophilic pneumonia as a cause of failure to wean from mechanical ventilation. Intensive Care Med 16:408–10.
Davis WB, Wilson HE, Wall RL (1986) Eosinophilic alveolitis in acute respiratory failure: a clinical marker for a non-infectious etiology. Chest 89: 7–10.
Carrington CB, Addington WW, Goff AM et al. (1969) Chronic eosinophilic pneumonia. N Engl J Med 280: 787–98.
Fox G, Seed WA (1980) Chronic eosinophilic pneumonia. Thorax 35: 870–80.
Jederlinic PJ, Sicillian L, Gaensler EA (1988) Chronic eosinophilic pneumonia: a report of 19 cases and a review of literature. Medicine 67: 154–62.
Naughton M, Fahy J, Fitzgerald MX (1993) Chronic eosinophilic pneumonia; A long-term follow-up of 12 patients. Chest 103: 162–5.
Wellor PF, Bubley (1994) The idiopathic hypereosinophilic syndrome. Blood 83: 2759–79.
Spry CJF, Davies J, Tai PC et al. (1983) Clinical features of fifteen patients with the hypereosinophilic syndrome. Quart J Med 205: 1–22.
Chusid JF, Dale DC, West BC et al. (1975) The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine 54: 1–27.
Parrillo JE, Borer JS, Henery WL et al. (1979) The cardiovascular manifestations of the hyper-eosinophilic syndrome. Prospective study of 26 patients, with review of the literature. Am J Med 67: 572–82.
Zielinski RM, Lawrence WD (1990) Interferon- alpha for the hypereosinophilic syndrome. Ann Intern Med 113: 716–8.
Zabel P, Schlaak M (1991) Cyclosporin for hyper-eosinophilic syndrome. Ann Hematol 62: 230–1.
Smit AJ, van Essen LH, de Vries EGE (1991) Successful long-term control of idiopathic hyper-eosinophilic syndrome with etoposide. Cancer 67: 2826–7.
Hinson KFW, Moon AJ, Plummer NS (1952) Broncho-pulmonary aspergillosis. A review and a report of eight new cases. Thorax 7: 317–33.
McAller R, Kroenert DB, Elder JF et al. (1981) Allergic bronchopulmonary disease caused by Curvularia lunata and Drechslera hawaiiensis. Thorax 36: 338–44.
Benatar SR, Allan B, Hewitson RP et al. (1990) Allergic bronchopulmonary stemphyliosis. Thorax 35: 515–8.
Pepys J, Faux JA, Longbottom JL et al. (1968) Candida albicans precipitins in respiratory disease in man. J Allergy 41: 305.
Rosenberg M, Patterson R, Mintzer R et al. (1977) Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 86: 405–14.
Patterson R, Greenberger PA, Halwig JM et al. (1986) Allergic bronchopulmonary aspergillosis: natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 146: 916–8.
Ricketti AJ, Greenberger PA, Patterson R (1984) Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 74: 68–71.
Patterson R, Greenberger PA, Lee TM et al. (1987) Prolonged evaluation of patients with cortico-steroid-dependent asthma stage of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 80: 663–8.
Capewell S, Chapman BJ, Alexander F et al. (1989) Corticosteroid treatment and prognosis in pulmonary eosinophilia. Thorax 44: 925–9.
Churg J, Strauss L (1951) Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Path 27: 277–301.
Chumbley LC, Harrison EG, DeRemee RA (1977) Allergic granulomatosis and angiitis (Churg - Strauss syndrome): report and analysis of 30 cases. Mayo Clin Proc 52: 477–84.
Lanham JF, Elkon KB, Pusey CD et al. (1984) Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg - Strauss syndrome. Medicine 63: 65–81.
Churg J (1936) Allergic granulomatosis and granulomatous-vascular syndromes. Ann Allergy 21: 619–28.
Cooper BJ, Vacal E, Patterson R (1978) Allergic angiitis and granulomatosis: Prolonged remission induced by combined prednisone-azathioprine therapy. Arc Intern Med 138: 367–71.
MacFadyen R, Tron V, Keshmiri M et al. (1987) Allergic angiitis of Churg and Strauss syndrome. Response to pulse methylprednisolone. Chest 91: 629–31.
Mayo FR, Muller NL, Road J etal. (1982) Chronic eosinophilic pneumonia: CT findings in six cases. Am J Roentgenol 1989;153: 727–730.
Patterson R, Greenberger PA, Radin RC, Roberts M. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann of Intern Med 96: 286–91.
Patterson R, Greenberger PA, Halwig JM et al. (1986) Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 146: 916–8.
Greenberger PA, Miller TP, Roberts M et al. (1993) Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis. Ann Allergy 70: 333–8.
Neeld DA, Goodman LR, Gurney JW et al. (1990) Computerized tomography in the evaluation of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 142: 1200–5.
Crystal RG, Bitterman PB, Rennard SI et al. (1984) Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 310: 154–235.
Schwarz MI (1988) Idiopathic pulmonary fibrosis. West J Med 149: 199–203.
Coultas DB, Zumwalt RE, Black WC et al. (1994) The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 150: 967–72.
Johnston I, Britton J, Kinnear W etal. (1990) Rising mortality from cryptogenic fibrosing alveolitis. BMJ 301: 1017–21.
du Bois RM (1993) Idiopathic pulmonary fibrosis. Annu Rev Med 44: 441–50.
Schwarz MI, Dreisin RB, Pratt DS et al. (1978) Immunoflourescent patterns in the idiopathic inter-stitial pneumonias. J Lab Clin Med 91: 929–38.
Dreisen RB, Schwarz MI, Theofilopoulos AN et al. (1978) Circulating immune complexes in the idio-pathic interstitial pneumonias. N Engl J Med 298: 353–7.
Veda T, Ohta K, Suzuki N (1992) Yamguchi Metal. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis 146: 266–70.
Hogg JC (1995) Epstein-Barr virus and cryptogenic fibrosing alveolitis. Thorax 50: 1232.
Iwai K, Mori T, Yamada N et al. (1994) Idiopathic pulmonary fibrosis: epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med 150: 670–75.
Raghu G, Hert R (1993) Interstitial lung diseases: genetic predisposition and inherited interstitial lung diseases. Semin Respir Med 14: 323–32.
Corrin B, Dewar A (1996) Pathogenesis of idiopathic interstitial pulmonary fibrosis. Ultrstructural Pathol 20: 369–71.
Lynch JPIII, Standiford TJ, Rolfe MW et al. (1992) Neutrophilic alveolitis in idiopathic pulmonary fibrosis: The role of inerleukin-8. Am Rev Respir Dis 145: 1433.
Standiford TJ, Rolfe MW, Kunkel SL etal. (1998) Altered production of regulation of monocyte chemoattractant protein-1 from pulmonary fibroblasts isolated from patients with idiopathic pul-monary fibrosis. J Immunol. In press.
Broekelmann TJ, Limper AH, Colby TV et al. (1991) Transforming growth factor-1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sei USA 88: 6642.
Nagaoka I, Trapnell BC, Crystal RG (1990) Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis. J Clin Invest 5: 2023.
Baumgartner KB, Samet JM, Stidley CA et al. (1997) Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 155: 242–8.
Hiwatari N, Shimura S, Sasaki T et al. (1991) Prognosis of idiopathic pulmonary fibrosis in patients with mucous hypersecretion. Am Rev Respir Dis 143: 182–5.
Katzenstein ALA, Myers JL, Mazur MT (1986) Acute interstitial pneumonia: a clinicopathologic ultra- structual and cell kinetic study. Am J Surg Path 10: 256–67.
Pratt D, Schwarz MI, May J et al. (1979) Rapidly fatal pulmonary fibrosis: the accelerated variant of acute interstitial pneumonitis. Thorax 34: 587–93.
Mathieson JR, Mayo JR, Staples CA et al. (1989) Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 171: 111–6.
Muller NL, Miller RR, Webb WR et al. (1986) Fibrosing alveolitis: CT-pathologic correlation. Radiology 160: 585–8.
Wells AU, Rubens MB, du Bois RM, Hansell DM (1993) Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. Am J Roentgenol 161: 1159–65.
Wells AU, Hansell DM, Rubens MB et al. (1993) The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis 148: 1076–82.
Lee J, Im JG, Ahn J et al. (1992) Fibrosing alveolitis: prognostic implication of ground-glass attenuation at high-resolution CT. Radiology 184: 451–4.
Terriff B, Kwan S, Chan-Yeung M et al. (1992) Fibrosing alveolitis: chest radiography and CT as predictors of clinical and functional impairment at follow-up in 26 patients. Radiology 184: 445–9.
Johkoh T, Ikezoe J, Kohno N et al. (1994) High- resolution CT and pulmonary function test in collagen vascular disease: comparison with idiopathic pulmonary fibrosis. Eur J Radiol 18: 113–21.
Sampson C, Hansell DM (1992) The prevalence of enlarged mediastinal lymph nodes in asbestos- exposed individuals: a CT study. Clin Radiol 45: 340–2.
Bergin C, Castellino RA (1990) Mediastinal lymph node enlargement on CT scans in patients with usual interstitial pneumonitis. Am J Roentgenol 154: 251–4.
Chinet T, Jaubert F, Dusser D et al. (1990) Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis. Thorax 45: 675.
Keogh BA, Lakatos E, Price D et al. (1984) Importance of the lower respiratory tract in oxygen transfer: Exercise testing in patients with interstitial and destructive lung disease. Am Rev Respir Dis 129: s76.
Nugent KM, Peterson MW, Jolles H et al. (1989) Correlation of chest roentgenograms with pulmonary function and bronchoalveolar lavage in interstitial lung disease. Chest 96: 1224.
Drent M, Cobben NAM, Henderson RF et al. (1996) Usefulness of lactic acid dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J 9: 1736–42.
Labrune S, Chinet TH, Colligonon MA et al. (1994) Mechanisms of increased epithelial lung clearance of DPTA in diffuse fibrosing alveolitis. Eur Respir J 7: 651–6.
Rudd RM, Haslam PL, Turner-Warwick M (1981) Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis 124: 1–8.
Turner-Warwick M, Haslam PL (1987) The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis 135: 26–34.
Costabel U, Matthys H (1981) Different therapies and factors influencing response to therapy in idiopathic diffuse fibrosing alveolitis. Respiration 42: 141.
O’Donnell K, Keogh B, Cantin A et al. (1987) Pharmacologic suppression of the neutrophil com-ponent of the alveolitis in idiopathic pulmonary fibrosis. Am Rev Respir Dis 136: 288.
Johnson MA, Kwan S, Snell NJC et al. (1989) Randomized controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination for cryptogenic fibrosing alveolitis. Thorax 44: 280.
Baughman RP, Lower EE (1992) Use of intermittent intravenous cyclophosphamide for idiopathic pul-monary fibrosis. Chest 102: 1090.
Raghu G, DePaso WJ, Cain K et al. (1991) Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo controlled trial. Am Rev Respir Dis 144: 291–9.
Alton EW, Johnson M, Turner-Warwick M (1989) Advanced cryptogenic fibrosing alveolitis: Preliminary report on treatment with cyclosporin A. Respir Med 83: 277.
Peters SG, McDougall JC, Douglas WW et al. (1993) Colchicine in the treatment of pulmonary fibrosis. Chest 103: 101.
Grossman RF, Frost A, Zamel N et al. (1990) Results of single-lung transplantation for bilateral pulmonary fibrosis. N Engl J Med 322: 727.
Rosen SH, Castleman B, Liebow AA (1958) Pulmonary alveolar proteinosis. N Engl J Med 258: 1123–42.
Honda Y, Takahashi H, Shijubo N et al. (1993) Surfactant protein A concentration in bronchopul-monary lavage fluids of patients with pulmonary alveolar proteinosis. Chest 103: 469–99.
Alberti A, Luisetti M, Braschie A et al. (1995) Bronchoalveolar lavage fluid composition in alveolar proteinosis: early changes after therapeutic lavage. Am J Respir Crit Care Med 154: 817–20.
Hattore A, Kuroki Y, Takahashi H et al. (1996) Surfactant protein A accumulating in the alveoli of patients with pulmonary alveolar proteinosis: oligomeric structure and interaction with lipids. Am J Respir Cell Mol Bio 14: 608–19.
Voss T, Shafer KP, Nielsen PF et al. (1992) Primary structure differences of human surfactant-associ- ated proteins isolated from normal and proteinosis lung. Biochim Biophys Acta 1138: 261–7.
Crouch E, Persson A, Chang D (1993) Accumulation of surfactant protein D in human pulmonary alveolar proteinosis. Am J Pathol 142: 241–8.
Ramirez RJ, Harlan WR Jr. (1968) Pulmonary alveolar proteinosis. Nature and origin of alveolar lipid. Am J Med 45: 502–12.
Nogee LM, De Mello DE, Dehner LP et al. (1993) Brief Report: Deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 328: 407–10.
Eldar M, Shoenfeld Y, Zaizov R et al. (1979) Pulmonary alveolar proteinosis associated with Fanconi’s anemia. Respiration 38: 177–9.
McEuen DD, Abraham JL (1978) Particulate con-centrations in pulmonary alveolar proteinosis. Environ Res 17: 334–49.
McCunney RJ, Godefroi R (1989) Pulmonary alveolar proteinosis and cement dust. J Occup Med 31: 233–7.
Buechner HA, Ansari A (1969) Acute silicopro- teinosis. Dis Chest 55: 274–84.
Suratt PM, Winn WC Jr., Brody AR et al. (1977) Acute silicosis in tombstone sandblasters. Am Rev Respir Dis 115: 521–9.
Miller RR, Churg AM, Hutcheon M et al. (1984) Pulmonary alveolar proteinosis and aluminum dust exposure. Am Rev Respir Dis 130: 312–15.
Lakshminarayan S, Schwarz MI, Stanford RE (1976) Unsuspected pulmonary alveolar proteinosis com-plicating acute myelogenous leukemia. Chest 69: 433–5.
Aymard J, Gyger M, Lavallee R et al. (1984) A case of pulmonary alveolar proteinosis complicating chronic myelogenous leukemia. A peculiar pathologic aspect of busulfan lung? Cancer 53: 954–6.
Green D, Dighe P, Ali NO et al. (1980) Pulmonary alveolar proteinosis complicating chronic myelo- gous leukemia. Cancer 46: 1763–6.
Cordonnier C, Fleury-Feith J, Escudier E et al. (1994) Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemia patients. Am J Respir Crit Care Med 149: 788–94.
Doyle AP, Balcerzak SP, Wells CL et al. (1963) Pulmonary alveolar proteinosis with hematologic disorders. Arch Intern Med 112: 940–6.
Israel RH, Magnussen CR (1989) Are AIDS patients at risk for pulmonary alveolar proteinosis? Chest 96: 641–2.
Ruben FL, Talamo TS (1986) Secondary pulmonary alveolar proteinosis occurring in two patients with AIDS. Am J Med 80: 1187–90.
Reyes JM, Putong PB (1980) Association of pul-monary alveolar lipoproteinosis with mycobacterial infection. Am J Clin Pathol 74: 478–85.
Clague HW, Wallace AC, Morgan WKC (1983) Pulmonary interstitial fibrosis associated with alveolar proteinosis. Thorax 38: 865–6.
Hudson AR, Halprin GM, Miller JA et al. (1974) Pulmonary interstitial fibrosis following alveolar proteinosis. Chest 65: 700–2.
Honda Y, Kataoka K, Hayashi H et al. (1989) Alteration of acidic phospholipids in bronchoalveo- lar lavage fluids of patients with pulmonary alveolar proteinosis. Clin Chem Acta 181: 11–18.
Sahu S, DiAugustine RP, Lynn WS (1976) Lipids found in pulmonary lavage of patients with alveolar proteinosis and in rabbitt lung organelles. Am Rev Respir Dis 114: 177–85.
Suzuki Y, Fujita Y, Kogishi K (1989) Reconstruction of tubular myelin from synthetic lipids and protein associated with pig pulmonary surfactant. Am Rev Respir Dis 140: 75–81.
Harris JO (1979) Pulmonary alveolar proteinosis. Abnormal in vitro function of alveolar macrophages. Chest 76: 156–9.
Golde DW (1979) Alveolar proteinosis and the overfed macrophage. Chest 76: 119–20.
Golde DW, Territo M, Finley TN et al. (1976) Defective lung macrophages in pulmonary alveolar proteinosis. Ann Intern Med 85: 304–9.
Harris JO (1979) Pulmonary alveolar proteinosis: Abnormal in vitro function of alveolar macrophages. Chest 76: 156–9.
Nugent KM, Pesanti EL (1983) Macrophage function in pulmonary alveolar proteinosis. Am Rev Respir Dis 127: 780–1.
Hoffman RM, Dauber JH, Rogers RM (1989) Improvement in alveolar macrophage migration after therapeutic whole lung lavage in pulmonary alveolar proteinosis. Am Rev Respir Dis 139: 1030–2.
Stratton JA, Sieger L, Wasserman K (1981) The immunoinhibitory activities of the lung lavage materials and sera from patients with pulmonary alveolar proteinosis (PAP). J Clin Immunol 5: 81–6.
Jones CC (1960) Pulmonary alveolar proteinosis with unusual complicating infections. Am J Med 29: 713–22.
Andriole VT, Ballas M, Wilson GL (1964) The association of nocardiosis and pulmonary alveolar proteinosis. Ann Intern Med 60: 266–75.
Sunderland WA, Campbell RA, Edwards MJ (1972) Pulmonary alveolar proteinosis and pulmonary cryptococcosis in an adolescent boy. J Pediatr 80: 450–6.
Ranchod M, Bissell M (1979) Pulmonary alveolar proteinosis and cytomegalovirus infection. Arch Pathol Lab Med 103: 139–42.
Newell JD, Underwood GH Jr., Russo DJ et al. (1984) Computed tomographic appearance of pulmonary alveolar proteinosis in adults. J Comput Tomogr 8: 21–9.
Godwin JD, Muller NL, Takasugi JE (1988) Pulmonary alveolar proteinosis: CT findings. Radiology 169: 609–13.
Murch CR, Carr DH (1989) Computed tomography appearances of pulmonary alveolar proteinosis. Clin Radiol 40: 240–3.
Hoffman RM, Rogers RM (1991) Serum and lavage lactic dehydrogenase isoenzymes in pulmonary alveolar proteinosis. Am Rev Respir Dis 143: 42–6.
Musuda T, Shurma S, Sasaki H et al. (1991) Surfactant apoprotein-A concentration in sputum for diagnosis of pulmonary alveolar proteinosis. Lancet 337: 580–2.
Martin RJ, Coalson JJ, Rogers RM et al. (1980) Pulmonary alveolar proteinosis: the diagnosis by segmental lavage. Am Rev Respir Dis 121: 819–25.
Rogers RM, Braunstein MS, Shuman JF (1972) Role of bronchopulmonary lavage in the treatment of respiratory failure: a review. Chest (Suppl) 62: 95S–106S.
Rogers RM, Szidon JP, Shelburne J et al. (1972) Hemodynamic response of the pulmonary circulation to bronchopulmonary lavage in man. N Engl J Med 286: 1230–3.
Carrington BC, Liebow AA (1966) Lymphocytic interstitial pneumonia (abstract). Am J Pathol 48: 36a.
Koss MN, Hochholzer L, Langloss JM et al. (1987) Lymphoid interstitial pneumonia: clinicopathological and immunopathologic findings in 18 cases. Pathology 19: 178–85.
Turner RR, Colby TV, Doggett RS (1984) Well differentiated lymphocytic lymphoma, a study of 47 patients with primary manifestation in the lung. Cancer 54: 2088–96.
Talal N, Bunim J (1964) The development of malignant lymphoma in the course of Sjogren’s syndrome. Am J Med 36: 529.
Reich NE, McCormack LJ, Van Orstand HS (1974) Pseudolymphoma of the lung. Chest 65: 424–7.
Malamou-Mitsi V, Tsai MM, Greer JP et al. (1992) Lymphoid interstitial pneumonitis not associated with HIV infection: Role of Epstein-Barr virus. Mod Pathol 5: 487–91.
Strimlan CV, Rosenow EC, III, Divertie MB et al. (1976) Pulmonary manifestations of Sjogren’s syn-drome. Chest 70: 354–61.
Alkhayer M, McCann BG, Harrison BDW (1988) Lymphocytic interstitial pneumonitis in association with Sjogren’s syndrome. Br J Dis Chest 82: 305–9.
Strimlan CV, Rosenow EC III, Weiland LH et al. (1978) Lymphocytic interstitial pneumonitis: a review of 13 cases. Ann Intern Med 68: 616–21.
Bonner H, Jr., Ennis RS, Greelhoed GW et al. (1973) Lymphoid infiltration and amyloidosis of lung in Sjogren’s syndrome. Arch Pathol 95: 42–4.
Anderson I, Talal N (1972) The spectrum of benign to malignant lymphoproliferation in Sjogren’s syndrome. Clin Exp Immunol 10: 199–204.
Deheinzelin D, Capelozzi VL, Kairalla RA et al. (1996) Interstitial lung disease in primary Sjogren’s syndrome: Clinical-pathologic evaluation and response to treatment. Am J Respir Crit Care Med 154: 794–9.
Perreault C, Coosineau S, D’Angelo G et al. (1985) Lymphoid interstitial pneumonia after allogeneic bone marrow transplantation. Cancer 55: 1–9.
Church JA, Hart I, Saxon A et al. (1981) Lymphoid interstitial pneumonitis and hypogammaglobulinemia in children. Am Rev Respir Dis 124: 491–6.
Joshi VV, Oleske JM, Minnelor AB et al. (1985) Pathologic pulmonary findings in children with the acquired immunodeficiency syndrome: a study of ten cases. Hum Pathol 16: 241–6.
Scott GB, Buck BE, Leterman JG et al. (1984) Acquired immunodeficiency syndrome in infants. N Engl J Med 310: 76–81.
Goldman, H.S., Ziprkowski MN, Charytan M etal. (1985) Lymphocytic interstitial pneumonitis in chil-dren with AIDS: a perfect radiographie-pathologie correlation. AJR 145: 868A.
Solai-Celigny P, Couderc LV, Herman D et al. (1985) Lymphoid interstitial pneumonitis in acquired immunodeficiency syndrome-related complex. Am Rev Respir Dis 131: 956–60.
Ichikawa Y, Kinoshita M, Koga T et al. (1994) Lung cyst formation in lymphocytic interstitial pneumonitis: CT features J Comput Assist Tomog 18: 745–8.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag London Limited
About this chapter
Cite this chapter
Schwartz, M.I., Lynch, D. (1999). Diffuse Interstitial Pulmonary Fibrosis. In: Sperber, M. (eds) Diffuse Lung Disorders. Springer, London. https://doi.org/10.1007/978-1-4471-3440-4_20
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3440-4_20
Publisher Name: Springer, London
Print ISBN: 978-1-4471-3442-8
Online ISBN: 978-1-4471-3440-4
eBook Packages: Springer Book Archive